Drug Description in Trials / DrugBank / KEGG DRUG /

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Acetate[1] Acetate---[41] 1, 2, 6, 10, 13, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 171, 206, 222, 224, 225, 227, 235, 251, 265, 288, 298, 299
2ADVATE[1] Antihemophilic factor, human recombinant---[1] 288
3ADVATE (rAHF - PFM)[1] Antihemophilic factor, human recombinant---[1] 288
4ADVATE (rAHF-PFM)[1] Antihemophilic factor, human recombinant---[1] 288
5ADVATE 1000 IU powder and solvent for solution for injection[1] Antihemophilic factor, human recombinant---[1] 288
6ADVATE 1000IU powder and solvent for solution for injection[1] Antihemophilic factor, human recombinant---[1] 288
7ADVATE 500 IU powder and solvent for solution for injection[1] Antihemophilic factor, human recombinant---[1] 288
8Alphanate[1] Von Willebrand factor human---[1] 288
9Alphanate 1000 I.U.[1] Von Willebrand factor human---[1] 288
10Alphanate 1500 I.U.[1] Von Willebrand factor human---[1] 288
11Alphanate SD/HT[1] Von Willebrand factor human---[1] 288
12ALPHANATE*INF 1F 1000UI+F 10ML[1] Von Willebrand factor human---[1] 288
13ALPHANATE*INF 1F 1500UI+F 10ML[1] Von Willebrand factor human---[1] 288
14ALPHANATE*INF 1F 250UI+F 5ML[1] Von Willebrand factor human---[1] 288
15ALPHANATE*INF 1F 500UI+F 5ML[1] Von Willebrand factor human---[1] 288
16Antihemophilic Factor (Recombinant)----[1] 288
17APCC, aPCC + TXA----[1] 288
18ARC 1779----[2] 64, 288
19ARC1779----[2] 64, 288
20ARC1779 Injection----[2] 64, 288
21BAX 111----[1] 288
22BAX111----[1] 288
23Biostate----[1] 288
24Biostate®----[1] 288
25BIVV001 (rFVIIIFc-VWF-XTEN)----[1] 288
26Blood coagulation Factor VIII and vWF, human[1] Beroctocog alfa---[1] 288
27Blood sample----[20] 8, 13, 46, 49, 51, 53, 61, 66, 84, 88, 96, 97, 107, 127, 235, 274, 280, 288, 294, 299
28BORTEZOMIB[1] Bortezomib[1] D03150 [1] PSMB5 💬[8] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[17] 11, 13, 26, 28, 46, 49, 51, 61, 63, 64, 66, 222, 228, 256, 283, 288, 331
29Catridecacog[1] Catridecacog[1] D10532 --[2] 97, 288
30Chloride[1] Chloride ion---[28] 6, 11, 13, 14, 34, 41, 46, 50, 51, 53, 60, 67, 70, 96, 97, 107, 127, 168, 171, 193, 227, 228, 251, 288, 296, 297, 299, 338
31Cluvot----[1] 288
32Coagadex[1] Coagulation factor X human---[1] 288
33Coagulación factor VIII[1] Beroctocog alfa---[1] 288
34Coagulation factor VIII[1] Beroctocog alfa---[1] 288
35Coagulation factor X[1] Coagulation factor X human---[1] 288
36Coagulation factor XIII[1] Factor XIII (human)---[1] 288
37CoFactor----[2] 265, 288
38Cyclophosphamide[1] Cyclophosphamide[2] D00287 ,
D07760 		--[44] 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 205, 222, 224, 256, 274, 283, 284, 285, 288, 326, 331
39DDAVP[1] Desmopressin[1] D00291 [2] AVPR2,
F8 💬		[4] Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬[2] 75, 288
40DDAVP (Desmopressin)[1] Desmopressin[1] D00291 [2] AVPR2,
F8 💬		[4] Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬[1] 288
41Desmopressin[1] Desmopressin[1] D00291 [2] AVPR2,
F8 💬		[4] Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬[5] 6, 64, 72, 225, 288
42Desmopressin acetate[2] Acetate,
Desmopressin		[1] D00291 [2] AVPR2,
F8 💬		[4] Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬[2] 64, 288
43Desmopressine[1] Desmopressin[1] D00291 [2] AVPR2,
F8 💬		[4] Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬[2] 225, 288
44Efanesoctocog alfa[1] Efanesoctocog alfa[1] D12441 --[1] 288
45Emicizumab[1] Emicizumab[1] D10821 [2] F10,
F9 💬		[1] Complement and coagulation cascades 💬[1] 288
46Emicizumab (ACE910, RO5534262)[1] Emicizumab[1] D10821 [2] F10,
F9 💬		[1] Complement and coagulation cascades 💬[1] 288
47Emicizumab Injection[1] Emicizumab[1] D10821 [2] F10,
F9 💬		[1] Complement and coagulation cascades 💬[1] 288
48Eqwilate----[1] 288
49F13CD----[1] 288
50F8VR----[1] 288
51FACTANE 200 IU/ml----[1] 288
52Factor VIII[1] Beroctocog alfa---[1] 288
53Factor VIII concentrate[1] Beroctocog alfa---[1] 288
54Factor von Willebrand[1] Von Willebrand factor human---[1] 288
55FACTOR X[1] Coagulation factor X human---[1] 288
56Factor XIII[1] Factor XIII (human)---[3] 51, 97, 288
57Factor XIII Concentrate (Human)[1] Factor XIII (human)---[1] 288
58Factor XIII Concentrate (Human), Pasteurized[1] Factor XIII (human)---[1] 288
59Fanhdi----[1] 288
60FANHDI 100 UI----[1] 288
61Fanhdi 100 UI FVIII-120 UI FVW----[1] 288
62FANHDI 25 UI----[1] 288
63Fanhdi 25 UI FVIII-30 UI FVW----[1] 288
64FANHDI 250UI*1F 250UI+F 10ML----[1] 288
65FANHDI 50 UI----[1] 288
66Fanhdi 50 UI FVIII-60 UI FVW----[1] 288
67FANHDI*INF FL 250UI+SIR SOLV+S----[1] 288
68FANHDI*INF FL 500UI+SIR SOLV+S----[1] 288
69FANHDI*INF FL1000UI+SIR SOLV+S----[1] 288
70FANHDI*INF FL250UI+SIR SOLV+S----[1] 288
71Fibrogammin P----[1] 288
72Fibrogammin® P----[1] 288
73Fibrogammin®P----[1] 288
74FXIII Concentrate (Human)----[1] 288
75FXIII Concentrate (Human) (FXIII)----[1] 288
76Haemate P----[1] 288
77Haemate P® (Human Coagulation Factor VIII)[1] Antihemophilic factor human---[1] 288
78Haemate-P, Wilate[1] Von Willebrand factor human---[1] 288
79Haemate® P 250----[1] 288
80Hemlibra[1] Emicizumab[1] D10821 [2] F10,
F9 💬		[1] Complement and coagulation cascades 💬[1] 288
81Hemlibra®[1] Emicizumab[1] D10821 [2] F10,
F9 💬		[1] Complement and coagulation cascades 💬[1] 288
82HEMOFIX----[1] 288
83HUMAN COAGULATION FACTOR VIII[2] Antihemophilic factor human,
Beroctocog alfa		---[1] 288
84Human coagulation Factor VIII / von Willebrand Factor[3] Antihemophilic factor human,
Beroctocog alfa,
Von Willebrand factor human		---[1] 288
85Human coagulation factor VIII associated with Von Willebrand factor (VWF)[3] Antihemophilic factor human,
Beroctocog alfa,
Von Willebrand factor human		---[1] 288
86Human Coagulation Factor VIII, Von Willebrand Factor[3] Antihemophilic factor human,
Beroctocog alfa,
Von Willebrand factor human		---[1] 288
87HUMAN COAGULATION FACTOR VIII, VON WILLEBRAND FACTOR COMPLEX[3] Antihemophilic factor human,
Beroctocog alfa,
Von Willebrand factor human		---[1] 288
88HUMAN COAGULATION FACTOR VIII, VON WILLEBRAND HUMAN COAGULATION FACTOR[2] Antihemophilic factor human,
Beroctocog alfa		---[1] 288
89Human Coagulation FACTOR X[1] Coagulation factor X human---[1] 288
90Human factor X[1] Coagulation factor X human---[1] 288
91HUMAN VON WILLEBRAND FACTOR[1] Von Willebrand factor human---[1] 288
92Human von Willebrand factor (VWF) and coagulation factor VIII (FVIII)[2] Beroctocog alfa,
Von Willebrand factor human		---[1] 288
93Human VWF/FVIII concentrate----[1] 288
94Humate-P[1] Von Willebrand factor human---[1] 288
95IL-11[1] Oprelvekin[1] D05266 [1] IL11RA 💬[3] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway 💬[1] 288
96Interleukin 11[1] Oprelvekin[1] D05266 [1] IL11RA 💬[3] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway 💬[1] 288
97Interleukin-11[1] Oprelvekin[1] D05266 [1] IL11RA 💬[3] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway 💬[2] 96, 288
98Marketed plasma-derived VWF/FVIII concentrate----[1] 288
99Minirin[1] Desmopressin[1] D00291 [2] AVPR2,
F8 💬		[4] Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬[2] 64, 288
100Minrin----[1] 288
101Natriumchlorid[1] Sodium chloride[1] D02056 --[1] 288
102Natriumchlorid 0,9 %[1] Sodium chloride[1] D02056 --[1] 288
103Neumega (Oprelvekin, Interleukin 11, IL-11)[1] Oprelvekin[1] D05266 [1] IL11RA 💬[3] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway 💬[1] 288
104NN 1841----[1] 288
105NN1841----[1] 288
106OBI-1----[1] 288
107OBIZUR[1] Susoctocog alfa[1] D10831 --[1] 288
108Obyoctocog alfa----[1] 288
109Octanate[1] Beroctocog alfa---[1] 288
110OCTANATE 100 UI/ml, poudre et solvant pour solution injectable[1] Beroctocog alfa---[1] 288
111OCTANATE 50 UI/ml, poudre et solvant pour solution injectable[1] Beroctocog alfa---[1] 288
112OCTOCOG ALFA[1] Antihemophilic factor, human recombinant---[1] 288
113Octostim----[2] 64, 288
114Oprelvekin[1] Oprelvekin[1] D05266 [1] IL11RA 💬[3] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway 💬[1] 288
115Oprelvekin, Interleukin 11, IL-11[1] Oprelvekin[1] D05266 [1] IL11RA 💬[3] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway 💬[1] 288
116Optivate----[1] 288
117Optivate® (Human Coagulation Factor VIII)[2] Antihemophilic factor human,
Beroctocog alfa		---[1] 288
118Physiologische Kochsalzlösung Fresenius - Infusionslösung----[1] 288
119Phytomenadione[1] Phylloquinone---[1] 288
120Plasma-derived FVIII/VWF concentrate----[1] 288
121Prednisone[1] Prednisone[1] D00473 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[45] 2, 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 95, 96, 97, 113, 162, 164, 205, 222, 224, 228, 283, 284, 288, 299, 300, 307, 331
122Prothrombin[1] Prothrombin---[1] 288
123Prothrombin Complex Concentrate[2] Factor IX Complex (Human),
Prothrombin		---[1] 288
124RAHF[1] Antihemophilic factor, human recombinant---[1] 288
125Recombinant coagulation FVIII Fc – von Willebrand factor – XTEN fusion protein[1] Von Willebrand factor human---[1] 288
126Recombinant coagulation FVIII Fc –von Willebrand factor – XTEN fusion protein[1] Von Willebrand factor human---[1] 288
127Recombinant factor VIIII (rFVIII)----[1] 288
128Recombinant Factor XIII[1] Factor XIII (human)---[1] 288
129Recombinant Factor XIII (rFXIII)[1] Factor XIII (human)---[2] 97, 288
130RECOMBINANT HUMAN COAGULATION FACTOR VIII FC - VON WILLEBRAND FACTO[1] Antihemophilic factor human---[1] 288
131RECOMBINANT HUMAN COAGULATION FACTOR VIII FC - VON WILLEBRAND FACTOR -[3] Antihemophilic factor human,
Beroctocog alfa,
Von Willebrand factor human		---[1] 288
132RECOMBINANT HUMAN COAGULATION FACTOR VIII FC - VON WILLEBRAND FACTOR - XTEN FUSION PROTEIN[2] Antihemophilic factor human,
Von Willebrand factor human		---[1] 288
133RECOMBINANT HUMAN COAGULATION FACTOR VIII FC - VON WILLEBRAND FACTOR -XTEN FUSION PROTEIN[2] Antihemophilic factor human,
Von Willebrand factor human		---[1] 288
134Recombinant human von Willebrand Factor[2] Von Willebrand factor human,
Vonicog alfa		[1] D08681 --[1] 288
135Recombinant interleukin-11[1] Oprelvekin[1] D05266 [1] IL11RA 💬[3] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway 💬[1] 288
136Recombinant porcine coagulation factor VIII (B domain deleted)[1] Beroctocog alfa---[1] 288
137Recombinant porcine coagulation factor VIII (B-domain deleted)[1] Beroctocog alfa---[1] 288
138Recombinant von Willebrand Factor[1] Von Willebrand factor human---[1] 288
139Recombinant von Willebrand Factor (rVWF)[1] Von Willebrand factor human---[1] 288
140Recombinant von Willebrand Factor 1300IU[1] Vonicog alfa[1] D08681 --[1] 288
141Recombinant von Willebrand Factor 650IU[1] Vonicog alfa[1] D08681 --[1] 288
142Recombinant von Willebrand factor : recombinant FVIII (rVWF:rFVIII)[1] Von Willebrand factor human---[1] 288
143Recomibnant human Von Willebrand Factor[1] Vonicog alfa[1] D08681 --[1] 288
144RFVIIa[1] Coagulation factor VIIa Recombinant Human---[1] 288
145RFVIIa, rFVIIa + TXA[1] Coagulation factor VIIa Recombinant Human---[1] 288
146RFVIII----[1] 288
147Rituxan----[4] 46, 60, 256, 288
148RITUXIMAB[1] Rituximab[1] D02994 [1] MS4A1 💬[1] Hematopoietic cell lineage 💬[48] 11, 13, 14, 19, 26, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331
149RO5534262 EMICIZUMAB[1] Emicizumab[1] D10821 [2] F10,
F9 💬		[1] Complement and coagulation cascades 💬[1] 288
150Rurioctocog alfa pegol[1] Rurioctocog alfa pegol[1] D10760 --[1] 288
151RVWF----[1] 288
152Saline solution----[4] 2, 34, 288, 299
153Simvastatin[1] Simvastatin[1] D00434 [1] HMGCR 💬[4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬[21] 6, 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310
154Simvastatine[1] Simvastatin[1] D00434 [1] HMGCR 💬[4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬[3] 6, 13, 288
155Sodium chloride[2] Chloride ion,
Sodium chloride		[1] D02056 --[20] 6, 11, 13, 14, 34, 41, 46, 50, 51, 53, 60, 67, 70, 96, 168, 193, 227, 228, 288, 299
156SODIUM CHLORIDE SOLUTION 0.9%[2] Chloride ion,
Sodium chloride		[1] D02056 --[4] 51, 60, 288, 299
157Standard of Care for Haemophilia A----[1] 288
158Standard of Care FVIII Replacement therapy----[1] 288
159Steroid----[2] 107, 288
160TAK-672----[1] 288
161Tranexamic acid[1] Tranexamic acid[1] D01136 [1] PLG 💬[4] Complement and coagulation cascades, Influenza A, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection 💬[7] 46, 70, 215, 227, 274, 288, 299
162VEYONDI 650IU powder and solvent for solution for injection----[1] 288
163Veyvondi[1] Vonicog alfa[1] D08681 --[1] 288
164VEYVONDI 1300 IU powder and solvent for solution for injection[1] Vonicog alfa[1] D08681 --[1] 288
165VEYVONDI 1300I IU powder and solvent for solution for injection[1] Vonicog alfa[1] D08681 --[1] 288
166VEYVONDI 1300IU powder and solvent for solution for injection[1] Vonicog alfa[1] D08681 --[1] 288
167VEYVONDI 650IU powder and solvent for solution for injection[1] Vonicog alfa[1] D08681 --[1] 288
168Von willebrand factor[1] Von Willebrand factor human---[2] 64, 288
169Von Willebrand factor (Recombinant)[1] Von Willebrand factor human---[1] 288
170Von Willebrand factor and coagulation factor VIII in combination[2] Beroctocog alfa,
Von Willebrand factor human		---[1] 288
171Von Willebrand Factor Antigen[1] Von Willebrand factor human---[1] 288
172Von Willebrand Factor Ristocetin Cofactor[1] Von Willebrand factor human---[1] 288
173Von Willebrand Faktor----[1] 288
174Voncento[1] Von Willebrand factor human---[1] 288
175Voncento, Biostate®[1] Von Willebrand factor human---[1] 288
176Voncento®[1] Von Willebrand factor human---[1] 288
177VONICOG ALFA[1] Vonicog alfa[1] D08681 --[1] 288
178VWD factor VIII concentrate[1] Beroctocog alfa---[1] 288
179VWF gene analysis----[1] 288
180VWF replacement therapy with Wilate[1] Von Willebrand factor human---[1] 288
181VWF SD-35-DH----[1] 288
182VWF-containing products----[1] 288
183VWF/FVIII products----[1] 288
184WILATE[1] Von Willebrand factor human---[1] 288
185Wilate 1000[1] Von Willebrand factor human---[1] 288
186WILATE 1000 I.U.[1] Von Willebrand factor human---[1] 288
187WILATE 450[1] Von Willebrand factor human---[1] 288
188Wilate 500[1] Von Willebrand factor human---[1] 288
189WILATE 500 I.U.[1] Von Willebrand factor human---[1] 288
190WILATE 900[1] Von Willebrand factor human---[1] 288
191WILATE® 450[1] Von Willebrand factor human---[1] 288
192WILFACTIN----[1] 288
193Willfact----[1] 288
194Wiloctin----[1] 288